BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$324M
1-Year Est. Return
47.35%
This Fund
S&P 500
1 Year Est. Return
+47.35%
AUM
$324M
AUM Growth
+$1.9M
(+0.59%)
Holding
89
Top Buys
| 1 | +$6.97M | |
| 2 | +$5.93M | |
| 3 | +$5.48M | |
| 4 |
Payoneer
PAYO
|
+$4.81M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
+$4.37M |
Top Sells
| 1 | +$18.3M | |
| 2 | +$14.3M | |
| 3 | +$13.5M | |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$6.9M |
| 5 |
Disc Medicine
IRON
|
+$6.76M |
Sector Composition
| 1 | Healthcare | 63.81% |
| 2 | Financials | 18.18% |
| 3 | Technology | 8.81% |
| 4 | Consumer Discretionary | 7.9% |
| 5 | Energy | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
enGene Holdings
ENGN
$489M
| $30.3M | 9.37% |
3,360,937
+82,831
|
|
||
2
Nuveen Churchill Direct Lending
NCDL
$648M
| $28.6M | 8.82% |
2,143,626
-947,927
|
|
||
3
Blue Owl Capital
OBDC
$5.49B
| $26.1M | 8.06% |
2,045,070
|
|
||
4
Larimar Therapeutics
LRMR
$494M
| $26M | 8.02% |
6,823,690
+970,650
|
|
||
5
Cullinan Oncology
CGEM
$824M
| $24.3M | 7.51% |
2,350,972
-160,000
|
|
||
6
Compass Therapeutics
CMPX
$923M
| $18.6M | 5.74% |
3,466,525
+875,000
|
|
||
7
Holley
HLLY
$358M
| $17.1M | 5.29% |
4,146,636
-715,725
|
|
||
8
Context Therapeutics
CNTX
$284M
| $10.9M | 3.37% |
7,432,906
+25,000
|
|
||
9
Conduent
CNDT
$193M
| $9.26M | 2.86% |
4,822,422
+365,574
|
|
||
|
RPTX
10
DELISTED
Repare Therapeutics
RPTX
| $8.95M | 2.76% |
3,443,659
|
|
||
11
Civeo
CVEO
$321M
| $8.47M | 2.62% |
370,530
+53,119
|
|
||
12
Sagimet Biosciences
SGMT
$174M
| $7.36M | 2.27% |
1,243,877
-84,474
|
|
||
13
EyePoint Inc
EYPT
$1.17B
| $7.17M | 2.21% |
392,594
+25,000
|
|
||
14
Procore
PCOR
$8.56B
| $6.86M | 2.12% |
+94,264
|
|
||
15
Dell
DELL
$99.3B
| $6.78M | 2.09% |
53,848
+1,514
|
|
||
16
KalVista Pharmaceuticals
KALV
$878M
| $5.81M | 1.79% |
360,000
+235,000
|
|
||
|
MPLT
17
MapLight Therapeutics
MPLT
$868M
| $5.74M | 1.77% |
+327,058
|
|
||
18
Roivant Sciences
ROIV
$20.4B
| $5.71M | 1.76% |
263,249
-725,000
|
|
||
|
IMA
19
ImageneBio Inc
IMA
$67.1M
| $5.68M | 1.75% |
823,785
+282,861
|
|
||
20
Immix Biopharma
IMMX
$535M
| $5.16M | 1.59% |
+986,240
|
|
||
|
21
Ultragenyx Pharmaceutical
RARE
$2.1B
| $4.89M | 1.51% |
212,638
-209,800
|
|
||
22
Immuneering
IMRX
$352M
| $4.38M | 1.35% |
665,000
+115,000
|
|
||
|
PVLA
23
Palvella Therapeutics
PVLA
$1.91B
| $4.21M | 1.3% |
40,259
-55,000
|
|
||
24
Oric Pharmaceuticals
ORIC
$1.32B
| $4.21M | 1.3% |
+515,000
|
|
||
|
25
Payoneer
PAYO
$1.53B
| $3.98M | 1.23% |
+832,810
|
|